Leukoreduced Whole Blood for Transfusion: Validation and Routine Use

Presented by:

Peter Schubert, MSc, PhD
Clinical Associate Professor
Department of Pathology and Laboratory Medicine
University of British Columbia
Research Associate
Canadian Blood Services

Pampee Young, MD, PhD
Chief Medical Officer
Biomedical Services 
American Red Cross

Learning Objectives:

After participating in this educational activity, participants should be able to:

• Describe how LR WB will be used in the U.S. and its intended use in Canada.
• Discuss the validation data for platelet, plasma and RBC from Canadian in vitro study.
• Define the use of LR WB in active and massive bleeding and its flexibility in other applications.

Click here to register for the eCast.